Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).
about
The Future of Pharmaceutical Manufacturing SciencesHot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation.Design of experiments (DoE) in pharmaceutical development.Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologics.Process Supply Chains Management – Where are We? Where to Go Next?Sol-gel Silica Nanoparticles in Medicine: A Natural Choice. Design, Synthesis and Products
P2860
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design (QbD) and Process Analytical Technology (PAT).
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Strategic funding priorities i ...... s Analytical Technology (PAT).
@en
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design
@nl
type
label
Strategic funding priorities i ...... s Analytical Technology (PAT).
@en
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design
@nl
prefLabel
Strategic funding priorities i ...... s Analytical Technology (PAT).
@en
Strategic funding priorities in the pharmaceutical sciences allied to Quality by Design
@nl
P2093
P1476
Strategic funding priorities i ...... s Analytical Technology (PAT).
@en
P2093
Buket Aksu
Hans Lindén
Jarkko Ketolainen
Marcel de Matas
Marco Weimer
Staffan Folestad
Thomas De Beer
Wim Oostra
P304
P356
10.1016/J.EJPS.2012.06.009
P407
P577
2012-06-26T00:00:00Z